1. Home
  2. VRDN vs LOMA Comparison

VRDN vs LOMA Comparison

Compare VRDN & LOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRDN
  • LOMA
  • Stock Information
  • Founded
  • VRDN 2006
  • LOMA 1926
  • Country
  • VRDN United States
  • LOMA Argentina
  • Employees
  • VRDN N/A
  • LOMA N/A
  • Industry
  • VRDN Medical Specialities
  • LOMA Building Materials
  • Sector
  • VRDN Health Care
  • LOMA Industrials
  • Exchange
  • VRDN Nasdaq
  • LOMA Nasdaq
  • Market Cap
  • VRDN 1.5B
  • LOMA 1.3B
  • IPO Year
  • VRDN N/A
  • LOMA 2017
  • Fundamental
  • Price
  • VRDN $18.87
  • LOMA $7.60
  • Analyst Decision
  • VRDN Strong Buy
  • LOMA Strong Buy
  • Analyst Count
  • VRDN 11
  • LOMA 2
  • Target Price
  • VRDN $38.80
  • LOMA $15.00
  • AVG Volume (30 Days)
  • VRDN 877.5K
  • LOMA 726.8K
  • Earning Date
  • VRDN 11-11-2025
  • LOMA 11-05-2025
  • Dividend Yield
  • VRDN N/A
  • LOMA N/A
  • EPS Growth
  • VRDN N/A
  • LOMA N/A
  • EPS
  • VRDN N/A
  • LOMA 0.37
  • Revenue
  • VRDN $305,000.00
  • LOMA $559,741,122.00
  • Revenue This Year
  • VRDN N/A
  • LOMA $22.92
  • Revenue Next Year
  • VRDN $35,092.81
  • LOMA $25.84
  • P/E Ratio
  • VRDN N/A
  • LOMA $20.44
  • Revenue Growth
  • VRDN 5.90
  • LOMA N/A
  • 52 Week Low
  • VRDN $9.90
  • LOMA $7.35
  • 52 Week High
  • VRDN $27.20
  • LOMA $14.17
  • Technical
  • Relative Strength Index (RSI)
  • VRDN 52.46
  • LOMA 18.35
  • Support Level
  • VRDN $18.12
  • LOMA $7.71
  • Resistance Level
  • VRDN $20.51
  • LOMA $8.34
  • Average True Range (ATR)
  • VRDN 0.94
  • LOMA 0.44
  • MACD
  • VRDN -0.01
  • LOMA -0.15
  • Stochastic Oscillator
  • VRDN 34.66
  • LOMA 3.70

About VRDN Viridian Therapeutics Inc.

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).

About LOMA Loma Negra Compania Industrial Argentina Sociedad Anonima ADS

Loma Negra Cia Industria Argentina SA is a cement producer in Argentina. The company operates in five segments: Cement, masonry cement, and lime; Concrete; Rail services; Aggregates; and Others. The majority of its revenue derives from Cement, masonry cement, and lime segments.

Share on Social Networks: